Crumlin, UK, 7 October 2010 -- The Randox Endocrine Array has been developed to detect the following hormones in human serum or plasma samples:
• Cortisol (CORT)
• Dehydroepiandrosterone-sulphate (DHEAs)
• 17aHydroxyprogesterone (17aOHP)
• Leptin (LEPT)
These hormones perform various vital functions within the human body. They are involved in adrenal gland function, metabolism, the immune system as well as the maintenance of body weight and energy. They are helpful markers in the diagnosis of numerous conditions and diseases, some of which include; stress, hypoglycemia, cushings syndrome, addison’s disease, adrenal tumours, alopecia and nutritional depravation.
Designed for research and development usage, the Endocrine Array is capable of providing high quality, reliable results. This array utilises the proven multiplexing technique known as Biochip Array Technology. Biochip Array Technology allows the simultaneous detection of multiple analytes from one single sample, providing a more complete patient profile and diagnosis. Only a small sample volume is required, thus saving time whilst reducing patient discomfort. Biochip Array Technology is simple and straightforward as the biochips are ready to use, reducing preparation time and more importantly, time to result.
Randox also offer a range of fully and semi automated analysers on which to run the Endocrine Array to achieve the highest quality, accurate results. This array offers excellent sensitivity and precision so you can have confidence in the results.
About Randox
Headquartered in the United Kingdom, Randox Laboratories Ltd. is a market leader within the in vitro diagnostics industry, manufacturing high quality diagnostic products for laboratories worldwide. Our extensive product portfolio offers complete solutions within the fields of clinical chemistry, cardiology, forensic toxicology, veterinary, drug residues, life sciences, oncology, molecular diagnostics and internal and external quality control. Our goal is to ‘revolutionise healthcare through continuously improving diagnostic solutions.’ We continue to achieve this year after year due to our commitment and significant re-investment in Research and Development. Our innovative approach to diagnostics allows us to develop revolutionary products, specifically designed to provide more efficient, higher quality and reliable results, ensuring patients receive the right diagnosis at the right time.
For more information contact us at marketing@randox.com or visit www.randox.com.
